The phosphatidylinositol-3-kinase (PI3K) signaling pathway plays a critical role in the biology and aggressive course of pancreatic ductal adenocarcinoma (PDAC), yet pharmacological PI3K targeting has not resulted in meaningful clinical success. Through genetic and pharmacological screenings, we ide...
ORGANISM(S): Homo sapiens (Human)
